These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7323940)

  • 1. LSD as a discriminative stimulus: role of dorsal raphe nucleus.
    Minnema D; Krynock G; Young R; Glennon R; Rosecrans J
    Subst Alcohol Actions Misuse; 1980; 1(1):29-34. PubMed ID: 7323940
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of the serotoninergic raphe-hippocampus system for the antinocifensive effect of morphine].
    Dude C; Dude G; Andreas K
    Acta Biol Med Ger; 1979; 38(4):641-7. PubMed ID: 525141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous unit activity of neurons within the dorsal raphe nucleus of the neonatal rat.
    Gallager DW
    Life Sci; 1982 Jun; 30(24):2109-13. PubMed ID: 7109839
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute and chronic effects of LSD and 5-MeODMT on raphe-evoked dorsal root potentials in the cat.
    Larson AA
    Life Sci; 1984 Mar; 34(12):1193-201. PubMed ID: 6708724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The raphe neuronal system and serotonergic effects of LSD.
    Halaris AE; Rosenthal M; DeMet EM; Freedman DX
    Neuropharmacology; 1982 Aug; 21(8):811-6. PubMed ID: 6181428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociations between the effects of LSD on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Jacobs BL
    Science; 1979 Aug; 205(4405):515-8. PubMed ID: 451617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross generalization with LSD and yohimbine in the rat.
    Colpaert FC
    Eur J Pharmacol; 1984 Jul; 102(3-4):541-4. PubMed ID: 6489439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of intracranial administration of hallucinogens on operant behavior in the rat. I. Lysergic acid diethylamide.
    Mokler DJ; Stoudt KW; Sherman LC; Rech RH
    Pharmacol Biochem Behav; 1986 Oct; 25(4):717-25. PubMed ID: 3538062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of serotonergic neuronal activity: autoreceptors and pacemaker potentials.
    Aghajanian GK
    Adv Biochem Psychopharmacol; 1982; 34():173-81. PubMed ID: 6753509
    [No Abstract]   [Full Text] [Related]  

  • 12. Responses of serotonergic and non-serotonergic neurons in the rat nucleus raphe magnus to systemic lysergic acid diethylamide.
    Wei JB; Chiang CY
    Neurosci Res; 1986 Feb; 3(3):268-73. PubMed ID: 3703384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility.
    Fink H; Oelssner W
    Eur J Pharmacol; 1981 Nov; 75(4):289-96. PubMed ID: 7318915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD.
    Young R; Rosecrans JA; Glennon RA
    Life Sci; 1982 Jun; 30(24):2057-62. PubMed ID: 7109835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

  • 16. The discriminative stimulus properties of LSD: mechanisms of action.
    Kuhn DM; White FJ; Appel JB
    Neuropharmacology; 1978; 17(4-5):257-63. PubMed ID: 652138
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurohumoral determinants of sensitivity to LSD.
    Appel JB
    Psychopharmacol Bull; 1979 Jan; 15(1):50-1. PubMed ID: 33407
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of lysergic and diethylamide (LSD) and 2-bromolysergic acid diethylamide (BOL) on the striatal DOPA accumulation: influence of central 5-hydroxytryptaminergic pathways.
    Persson SA; Johansson H
    Brain Res; 1978 Mar; 142(3):505-13. PubMed ID: 25117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP).
    Cunningham KA; Carroll BA; Appel JB
    Psychopharmacology (Berl); 1986; 89(1):134-5. PubMed ID: 3090587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Effects of lysergic acid diethylamide on auditory and visual discrimination in the rat.
    Brown K; Cooper SJ
    Br J Pharmacol; 1975 Jun; 54(2):234P. PubMed ID: 1148524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.